相关实验视频

Updated: May 20, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

朗格汉斯细胞细胞形成的基因组变化

Nitya Gulati¹, Erin Peckham-Gregory², D Williams Parsons³

¹Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.

Hematology/oncology clinics of North America

|March 25, 2025

概括

朗格汉斯细胞囊细胞症 (LCH) 是一种罕见的髓状细胞癌,由MAPK通路突变驱动,通常是BRAFV600E. 识别这些突变有助于风险分层,并可能改善LCH患者的治疗结果.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

朗格汉斯细胞囊细胞症 (LCH) 是一种骨髓状瘤性疾病.
它的特征是具有克隆性囊细胞的炎症性病变.
激活基激活蛋白激酶 (MAPK) 路径突变驱动LCH病原体.

研究的目的:

审查MAPK途径突变在LCH.中的作用.
讨论BRAF^V600E突变的临床影响.
通过风险分层来探索LCH患者结局的潜在改善.

主要方法:

关于LCH病原和治疗的文献综述.
对突变数据的分析,包括BRAFV600E.
对遗传祖先和LCH发病率的讨论.

主要成果:

BRAF^V600E是最常见的突变,与严重的疾病和治疗耐药性有关.
遗传因素,特别是祖先,影响LCH发病率.
MAPK 抑制剂显示有效性,但很少实现治愈.

结论:

准MAPK路径突变对于LCH管理至关重要.
基于体质突变和外周血液分析的风险分层可能会改善患者的治疗结果.
需要进一步的临床试验来验证这些方法.

关键词:

BRAF (V600E) 是一个囊细胞性疾病囊细胞性疾病兰格拉汉斯细胞基细胞分裂通过MAPK路径.

更多相关视频

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...